Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder

By Zhu Baojin   Kulkarni Pandurang M   Stensland Michael D.   Ascher-Svanum Haya  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2805-2814

Informa Healthcare

Access to resources Recommend Favorite

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia*

By Edwards Natalie C.   Pesa Jacqueline   Meletiche Dennis M.   Engelhart Luella   Thompson Ann K.   Sherr Jay   Dirani Riad  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3341-3355

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK**

By Davies Andrew   Vardeva Kawitha   Loze Jean-Yves   L’’Italien Gilbert J.   Sennfalt Karin   Baardewijk Marc van  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3275-3285

Informa Healthcare

Access to resources Recommend Favorite

Copy variations in schizophrenia and bipolar disorder

By  

Cytogenetic and Genome Research, Vol. 123, Iss. 1-4, 2009-03 ,pp. : 27-35

Karger

Access to resources Recommend Favorite

Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole

By Potkin Steven G.   Raoufinia Arash   Mallikaarjun Suresh   Bricmont Patricia   Peters-Strickland Timothy   Kasper William   Baker Ross A.   Eramo Anna   Sanchez Raymond   McQuade Robert  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite